Instrumental in the issuance of the patents by the USPTO were David Rosenbaum and Donna Becker of Rosenbaum & Associates, P.C. of Northbrook, IL. "If it was not for David's interest and belief in HemoGenix and Donna's exuberance in learning and obtaining a thorough understanding of our work and products and her persistence and communication with the USPTO, we would certainly not be in this position today," said Ivan Rich, Ph.D., Founder and CEO of HemoGenix(R). "For a small, but growing company like HemoGenix(R), IP is of fundamental importance to us, not only as validation for what we do, but also for future business, market share and strategic partnerships. This is an important milestone for us. I am extremely grateful to David Rosenbaum and Donna Becker for all the help, assistance and trust they have given us and continue to give us."
About HemoGenix(R), Inc.
HemoGenix(R) Inc., a privately-held contract research and assay development company was started in 2000 in South Carolina and relocated to Colorado Springs, Colorado in 2003. HemoGenix has developed its own portfolio of proprietary and now patented in vitro assay platforms for basic research, stem cell quality control, potency and release assays for stem cell transplantation processing laboratories and toxicity, safety and risk assessment for drug development and environmental testing. HemoGenix(R) develops and validates its in vitro assays first for its contract services and then as assay kits for in house use that are sold directly or through its distributors worldwide.
About Rosenbaum & Associates, P.C.
Rosenbaum & Associates, P.C., located in Northbrook, IL, is a full
spectrum intellectual property law firm providing services for the life
sciences community. The firm specializes in meeting the needs of start-up
and emerging companies and has successfully worked with ind
|SOURCE HemoGenix(R), Inc.|
Copyright©2008 PR Newswire.
All rights reserved